Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

Candida Auris: Review on worldwide spread, seems prone to antifungal and disinfectant therapies

Breadcrumb

  • Home
  • Candida Auris: Review on worldwide spread, seems prone to antifungal and disinfectant therapies

Vaishnavi V Khairnar 1, *, Yogesh S Wankhede 2 and Amol R Patil 1

1 Department of Pharmaceutical Chemistry, Srujan Foundations, G. D. Burkule Institute of Research and Education in Pharmaceutical Sciences, Cidco Nashik Maharashtra, India.

2 Department of Pharmaceutical Chemistry, METs Institute of D Pharmacy, Adgaon Nashik Maharashtra, India.

Review Article

World Journal of Biology Pharmacy and Health Sciences, 2025, 21(01), 547-560

Article DOI: 10.30574/wjbphs.2025.21.1.0072

DOI url: https://doi.org/10.30574/wjbphs.2025.21.1.0072

Received on 07 December 2024; revised on 23 January 2025; accepted on 26 January 2025

In recent years, C. auris has become a leading source of invasive fungal diseases, with outbreaks occurring across all continents. This fungus infection poses a severe hazard to healthcare, with outbreaks primarily affecting older patients with comorbidities and high fatality rates. Controlling epidemics has been challenging because to poor detection, fast spread, and resistance to environmental cleaning methods. C. auris is currently the major cause, or one of the leading causes of invasive fungal infections in many healthcare facilities, primarily due to its potential may exhibit or acquire resistance to many types of antifungal medications and due to their Ability to persevere in healthcare circumstances. Timely diagnosis by swift and reliable identification. techniques and dedication in infection control procedures can assist to limit the spread of C. auris, and prevent and manage epidemics

Candida Auris; Antimicrobial Resistance; Environmental Conditions; Treatments; Hospital Outbreaks

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2025-0072.pdf

Preview Article PDF

Vaishnavi V Khairnar, Yogesh S Wankhede and Amol R Patil. Candida Auris: Review on worldwide spread, seems prone to antifungal and disinfectant therapies. World Journal of Biology Pharmacy and Health Sciences, 2025, 21(01), 547-560. Article DOI: https://doi.org/10.30574/wjbphs.2025.21.1.0072.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution